Belinostat - Small Molecule (ID:10310-101)
HMS LINCS ID: | 10310-101 |
Name: | Belinostat |
Alternative Names: | PXD101 |
LINCS ID: | LSM-43181 |
PubChem CID: | 53437714 |
ChEBI ID: | |
ChEMBL ID: | |
Molecular Mass: | 318.07 |
InChi: | InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18) |
InChi Key: | NCNRHFGMJRPRSK-UHFFFAOYSA-N |
SMILES: | C1=CC=C(C=C1)NS(=O)(=O)C2=CC=CC(=C2)C=CC(=O)NO |
Relevant Citations: | |
Comments: | |
Date Publicly Available: | |
Most Recent Update: | 2018-03-30 |
Target Affinity:
(see Study 20000)Target Affinity Spectrum Value | HUGO Gene Name |
---|---|
HDAC1, HDAC10, HDAC11, HDAC2, HDAC3, HDAC6, HDAC7, HDAC8 | |
2 (equivalent to 100 nM ≤ Kd < 1µM) | HDAC4, HDAC5, HDAC9 |
10 (confirmed non-binding) |
Datasets:
HMS Dataset ID | Dataset Title | HMS Dataset Type |
---|---|---|
20000 | Target Affinity Spectrum (TAS) vectors for compounds in the HMS LINCS small molecule library. | Analysis |
20272 | Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (viability/apoptosis dataset 1 of 2) | Microscopy/Imaging |
20273 | Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) | Microscopy/Imaging |
20276 | Protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with Vemurafenib in combination with chromatin-targeting compounds (immunofluorescence dataset 3 of 4) | Microscopy/Imaging |
20277 | Phosphorylation state and protein levels measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of two compounds (immunofluorescence dataset 4 of 4) | Microscopy/Imaging |
Batch Information:
HMS LINCS Batch ID | Provider | Provider Batch ID |
---|---|---|
10310-101-1 | Haoyuan chemexpress | HY-10225-20111013 |
(Kd <100 nM)